Eptifibatide plus tPA looks promising for ischemic stroke

A phase 2 study has suggested that the GP IIb/IIIa blocker can be safely combined with a reduced dose of tPA, and there was a sufficient signal of efficacy to justify a phase 3 trial.

Source: theHeart.org - February 15, 2013 Category: Cardiology Source Type: news